Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Syneron Medical Ltd (NASDAQ:ELOS)

10.95
Delayed Data
As of Jun 23
 0.00 / 0.00%
Today’s Change
6.18
Today|||52-Week Range
11.43
+30.36%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues75.0M71.5M82.9M66.9M
 
 
 
 
 
Cost of Goods Sold34.3M32.6M36.0M30.4M
 
 
 
 
 
Depreciation And Amortization2.0M1.9M2.5M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income38.6M37.0M44.3M34.2M
 
 
 
 
 
General Expenses36.3M35.3M39.9M36.3M
 
 
 
 
 
Research And Development5.8M5.4M6.1M6.2M
 
 
 
 
 
Total Operating Expenses72.6M69.8M78.5M69.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.4M1.7M4.4M-2.1M
 
 
 
 
 
Other Expenses-321.0K-276.0K-3.7M-2.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.0M1.5M696.0K-4.6M
 
 
 
 
 
Income Taxes-1.1M-885.0K-1.6M-236.0K
 
 
 
 
 
Net Income982.0K588.0K-896.0K-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.3M34.7M34.7M34.9M
 
 
 
 
 
Shares To Calculate EPS Diluted35.5M34.9M34.7M34.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.03$0.02-$0.03-$0.14
 
 
 
 
 
EPS Diluted$0.03$0.02-$0.03-$0.14